Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1000 participants
OBSERVATIONAL
2024-09-01
2024-10-17
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
What are the risk factors for the development of sepsis? How do we improve the prognosis of sepsis?
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study on the Construction and Application of Early Warning Model of Sepsis in Critically Ill Patients
NCT06904001
Effect of Immunophenotype on Prognosis of Sepsis
NCT05602584
The Role of NLR in the Diagnosis and Prognosis of Sepsis
NCT05636202
Risk Factors for Adverse Outcomes in Sepsis
NCT06541600
Co-inhibitory Molecules on Treg and miR-155-5p in Patients With Sepsis
NCT05126537
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sepsis Group
Tumor Necrosis Factor
This study is a retrospective observational study, with Tumor Necrosis Factor being one of the exposure factors under investigation.
Interleukin-1β
This study is a retrospective observational study, with Interleukin-1β being one of the exposure factors under investigation.
Interleukin-12
This study is a retrospective observational study, with Interleukin-12 being one of the exposure factors under investigation.
Interleukin-18
This study is a retrospective observational study, with Interleukin-18 being one of the exposure factors under investigation.
Complement C3
This study is a retrospective observational study, with Complement C3 being one of the exposure factors under investigation.
Complement C5
This study is a retrospective observational study, with Complement C5 being one of the exposure factors under investigation.
Non-Sepsis Group
Tumor Necrosis Factor
This study is a retrospective observational study, with Tumor Necrosis Factor being one of the exposure factors under investigation.
Interleukin-1β
This study is a retrospective observational study, with Interleukin-1β being one of the exposure factors under investigation.
Interleukin-12
This study is a retrospective observational study, with Interleukin-12 being one of the exposure factors under investigation.
Interleukin-18
This study is a retrospective observational study, with Interleukin-18 being one of the exposure factors under investigation.
Complement C3
This study is a retrospective observational study, with Complement C3 being one of the exposure factors under investigation.
Complement C5
This study is a retrospective observational study, with Complement C5 being one of the exposure factors under investigation.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Tumor Necrosis Factor
This study is a retrospective observational study, with Tumor Necrosis Factor being one of the exposure factors under investigation.
Interleukin-1β
This study is a retrospective observational study, with Interleukin-1β being one of the exposure factors under investigation.
Interleukin-12
This study is a retrospective observational study, with Interleukin-12 being one of the exposure factors under investigation.
Interleukin-18
This study is a retrospective observational study, with Interleukin-18 being one of the exposure factors under investigation.
Complement C3
This study is a retrospective observational study, with Complement C3 being one of the exposure factors under investigation.
Complement C5
This study is a retrospective observational study, with Complement C5 being one of the exposure factors under investigation.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Pregnant Women
* Patients with Advanced-Stage Cancer and Systemic Metastasis
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Second Affiliated Hospital of Wenzhou Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Xiue Ye
Wenzhou, Zhejiang, China
The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University,
Wenzhou, Zhejiang, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SAHoWMU-CR2024-16-214
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.